A Phase II Open-Label, Multi-Center Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Patients with Previously Treated Peripheral T-Cell Lymphoma(PTCL)
暂无分享，去创建一个
B. Coiffier | F. d'Amore | J. Radford | P. Zinzani | C. Haioun | F. Morschhauser | C. Thieblemont | P. Fields | M. Chamuleau | D. Caballero | K. Dwyer | G. W. Imhoff | C. García | A. Saunders | E. G. Barca | P. Johnson